With Injuries Rising Late in Football Season, ZetrOZ Systems’ Sustained Acoustic Medicine Provides Recovery Option
The sam® wearable ultrasound unit appears in a new documentary on one player’s efforts to stay in the game.
TRUMBULL, Conn., November 21, 2023 (Newswire.com) - With more than 130 National Football League players reported injured and potentially unable to play last week, teams need ways to help players recover more quickly and return to the field. The sam® wearable ultrasound unit from ZetrOZ Systems is a proven solution for improving recovery from the soft tissue injuries prevalent in the sport.
ZetrOZ Systems, founded by biomedical engineer Dr. George K. Lewis, works closely with orthopedic physicians, sports medicine physicians, and athletic trainers for professional and amateur sports teams, including football, baseball, and hockey.
The ZetrOZ sam® device appears in “Kelce,” a new Amazon Original documentary about Philadelphia Eagles All-Pro center Jason Kelce, who plays one of the most physically challenging positions in the game and has considered retiring because of repeated injuries. In one segment, the movie shows Kelce at home, applying the sam® wearable ultrasound device to his right elbow and triceps. Kelce says he uses the ultrasound treatment to “pump the soreness out.”
ZetrOZ Systems’ sustained acoustic medicine technology increases blood vessel diameters to improve blood flow. That increases oxygenated hemoglobin at the therapy site and removes cytokine enzymes and cellular waste for more rapid soft tissue healing.
Soft tissue injuries to limbs and joints are common in football because players need to move and change directions at high speed and the physical contact inherent to the sport. A study by sports medicine physicians at the University of Pittsburgh Medical Center found ankle sprains and strains of the quadriceps, hamstring, and groin areas among the most common football injuries.
The effectiveness of ZetrOZ’s sam® sustained acoustic medicine in treating soft tissue and other injuries has been documented in 42 peer-reviewed publications and 20 Level 1-5 clinical studies.
A 2022 study by authors including three respected college athletic trainers examined sam® usage by 239 healthcare providers for treating injuries to tendons and ligaments, joints, large muscle groups, and bone. They reported that sam® provided clinical improvement in under two weeks in more than two-thirds of cases (68.9%), resulting in a 50% reduction in pain medication.
A 2015 Level 4 clinical study by sports medicine experts at Ohio State University and Duke University found sustained acoustic medicine delivered via ZetrOZ's sam® reduced pain and improved strength in patients' medial/lateral elbow tendons and Achilles tendons.
"We know that players across a broad spectrum of sports rely on our sam® device to help heal their soft tissue injuries more effectively. It’s immensely gratifying to know that we can help them recover, without invasive surgery and with less need for pain medications, and rejoin their teammates more quickly," said Lewis, also CEO of ZetrOZ Systems.
ZetrOZ's sam® devices are the only FDA-cleared wearable ultrasound units approved for daily use at home. ZetrOZ's technology was developed, in part, with funding from the National Institute of Health, National Science Foundation, Department of Defense, and NASA. ZetrOZ Systems products are designed and manufactured in the United States and are protected by 46 U.S. patents.
To learn more, visit www.samrecover.com.
About ZetrOZ Systems
ZetrOZ Systems is leading healing innovations in sports medicine, developing wearable bioelectronic devices for the delivery of sustained acoustic medicine (sam®). Researched and funded by the federal government, ZetrOZ is built on the proprietary medical technology of 46 patents and is the exclusive manufacturer and developer of the sam® product line, which is designed for the treatment of acute and chronic musculoskeletal conditions.
Source: ZetrOz Systems
